ArticleHepatology international2022
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.
Registry-linked trialAbstract readEditorial
In one paragraph
Article in Hepatology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07149675 (A Multi-center Prospective-retrospective Study of the Clinical Characteristics, Biochemical Response, and Long-term Outcomes in Patients With Primary Biliary Cholangitis), which is not on this map. Cited by 79 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Multi-center Prospective-retrospective Study of the Clinical Characteristics, Biochemical Response, and Long-term Outcomes in Patients With Primary Biliary Cholangitis
Who cites it
79 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Bibliometric analysis of research on intestinal flora and primary biliary cholangitis published between 2004 and 2024 using VOSviewer and CiteSpace visualization.Frontiers in medicine · 2025Pooled it
- Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis.Frontiers in pharmacology · 2023Pooled it
- Hsa_circ_0000711 can serve as a novel biomarker for primary biliary cholangitis by promoting disease progression through the regulation of miR-185-5p and NFATc3.RNA biology · 2026Article
- Advances in pharmacological interventions for hepatic fibrosis: from pathogenic mechanisms to novel therapeutic targets.Annals of medicine · 2026Review
- Neutrophil extracellular traps drive cholangiocyte injury via ZNF709-TP53-MDM2 pathway in primary biliary cholangitis.Hepatology international · 2026Article
- Prognostic nutritional index as a predictor of ursodeoxycholic acid response in primary biliary cholangitis: a retrospective study.BMC gastroenterology · 2026Article
- Autoantibodies in the diagnostics, prognostics and follow-up of primary biliary cholangitis.Journal of translational autoimmunity · 2026Review
- Optimizing Care in Primary Biliary Cholangitis: Current Treatments and the Second-Line Decision.Digestive diseases and sciences · 2026Review
- Primary Biliary Cholangitis Presenting with Low Back Pain and Complicated by Immune-Mediated Necrotizing Myositis: A Case Report.European journal of rheumatology · 2026Article
- Direct bilirubin was superior to total bilirubin in predicting the long-term outcomes of patients with primary biliary cholangitis.BMC gastroenterology · 2026Article
- Factors associated with recompensation and criteria for etiological suppression in patients with primary biliary cholangitis.Journal of gastroenterology · 2026Article
- Development and evaluation of explainable machine learning models for predicting prognosis in patients with primary biliary cholangitis.Frontiers in molecular biosciences · 2026Article
- Pyroptosis Plays a Key Role Through Macrophages in Primary Biliary Cholangitis of Mice.BioMed research international · 2026Article
- Ferroptosis regulatory networks and precision interventions in autoimmune hepatitis: comparison with cholestatic diseases.Frontiers in immunology · 2026Review
- Serum matrix metalloproteinase-7 as a diagnostic and prognostic biomarker in primary biliary cholangitis.Frontiers in medicine · 2026Article
- Genetic evidence supports primary biliary cholangitis as a risk factor for lacunar stroke.iScience · 2025Article
- The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives.Journal of personalized medicine · 2025Review
- Optimizing clinic consultations in primary biliary cholangitis: International consensus recommendations.Hepatology communications · 2025Article
- Rare liver diseases - Etiology, diagnosis and management: A review.Biomolecules & biomedicine · 2025Review
- Advancing the management of primary biliary cholangitis: From pathogenesis to emerging therapies.World journal of clinical cases · 2025Review
19 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Hong You *Liver Research Center, Beijing Friendship Hospital, Capital Medical University, 95 Yong-an Road, Beijing, Mainland, China.
Xiong Ma *Department of Gastroenterology and Hepatology, Renji Hospital, Shanghai Jiao Tong University, Shanghai, Mainland, China.
Cumali Efe *Department of Gastroenterology, Gazi Yaşargil Education and Research Hospital, Diyarbakir, Turkey.
Guiqiang WangDepartment of Infectious Diseases and Center for Liver Diseases, Peking University First Hospital, Beijing, Mainland, China.
Sook-Hyang JeongDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seoul, South Korea.
Kazumichi AbeDepartment of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Weijia DuanLiver Research Center, Beijing Friendship Hospital, Capital Medical University, 95 Yong-an Road, Beijing, Mainland, China.
Sha ChenLiver Research Center, Beijing Friendship Hospital, Capital Medical University, 95 Yong-an Road, Beijing, Mainland, China.
Yuanyuan KongClinical Epidemiology and EBM Unit, Beijing Friendship Hospital, Capital Medical University, Beijing, Mainland, China.
Dong ZhangExperimental and Translational Research Center, Beijing Clinical Research Institute, Beijing, Mainland, China.
Lai WeiHepatobiliary Pancreatic Center, Tsinghua Changgung Hospital, Tsinghua University, Beijing, Mainland, China.
Fu-Sheng WangTreatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospial, Beijing, Mainland, China.
Han-Chieh LinDivision of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Jin Mo YangDivision of Hepatology, Department of Internal Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, South Korea.
Tawesak TanwandeeDivision of Gastroenterology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Rino A GaniDepartment of Internal Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia.
Diana A PayawalDepartment of Medicine, Fatima University Medical Center, Manila, Philippines.
Barjesh C SharmaDepartment of Gastroenterology, GB Pant Hospital, New Delhi, India.
Jinlin HouDepartment of Infectious Disease and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, Mainland, China.
Osamu YokosukaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
A Kadir DokmeciDepartment of Medicine, Ankara University School of Medicine, Ankara, Turkey.
Darrell CrawfordSchool of Medicine, University of Queensland, Brisbane, Australia.
Jia-Horng KaoDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Teerha PiratvisuthNKC Institute of Gastroenterology and Hepatology, Faculty of Medicine, Prince of Songkla University, Hatyai, Thailand.
Dong Jin SuhDepartment of Gastroenterology, University of Ulsan College of Medicine, Seoul, South Korea.
Laurentius A LesmanaDigestive Disease and GI Oncology Centre, Medistra Hospital, Jakarta, Indonesia.
Jose SollanoDepartment of Medicine, University of Santo Tomas, Manila, Philippines.
George LauHumanity and Health Clinical Trial Center, Humanity and Health Medical Group, Hong Kong SAR, China.
Shiv K SarinDepartment of Hepatology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, India.
Masao OmataDepartment of Gastroenterology, Yamanashi Central Hospital, Yamanashi, Japan. momata-tky@umin.ac.jp.
Atsushi TanakaDepartment of Medicine, Teikyo University School of Medicine, Tokyo, Japan. tanaka@med.teikyo-u.ac.jp.
Jidong JiaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, 95 Yong-an Road, Beijing, Mainland, China. jia_jd@ccmu.edu.cn.ORCID http://orcid.org/0000-0002-4673-8890
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
CholangitisLiver Cirrhosis, BiliaryHumans
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT07149675ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.